Literature DB >> 36033917

Epileptogenic zone localization using intraoperative gamma oscillation regularity analysis in epilepsy surgery for cavernomas: patient series.

Yosuke Sato1, Yoshihito Tsuji2, Yuta Kawauchi1, Kazuki Iizuka1, Yusuke Kobayashi1, Ryo Irie1, Tatsuya Sugiyama1, Tohru Mizutani1.   

Abstract

BACKGROUND: In epilepsy surgery for cavernoma with intractable focal epilepsy, removal of the cavernoma with its surrounding hemosiderin deposition and other extended epileptogenic zone has been shown to improve postsurgical seizures. However, there has been no significant association between such an epileptogenic zone and intraoperative electrocorticography (ECoG) findings. The authors recently demonstrated that high regular gamma oscillation (30-70 Hz) regularity (GOR) significantly correlates with epileptogenicity. OBSERVATIONS: The authors evaluated the utility of intraoperative GOR analysis in epilepsy surgery for cavernomas. The authors also analyzed intraoperative ECoG data from 6 patients with cavernomas. The GOR was calculated using a sample entropy algorithm. In 4 patients, the GOR was significantly high in the area with the pathological hemosiderin deposition. In 2 patients with temporal cavernoma, the GOR was significantly high in both the hippocampus and the area with the pathological hemosiderin deposition. ECoG showed no obvious epileptic waveforms in 3 patients, whereas extensive spikes were observed in 3 patients. All patients underwent cavernoma removal plus resection of the area with significantly high GOR. The 2 patients with temporal cavernomas underwent additional hippocampal transection. All patients were seizure free after surgery. LESSONS: The high GOR may be a novel intraoperative marker of the epileptogenic zone in epilepsy surgery for cavernomas.
© 2021 The authors.

Entities:  

Keywords:  ECoG = electrocorticography; EEG = electroencephalographic; GOR = gamma oscillation (30–70 Hz) regularity; SD = standard deviation; cavernoma; epilepsy surgery; epileptogenic zone; gamma oscillation regularity; sample entropy

Year:  2021        PMID: 36033917      PMCID: PMC9394110          DOI: 10.3171/CASE20121

Source DB:  PubMed          Journal:  J Neurosurg Case Lessons        ISSN: 2694-1902


Cavernomas are benign vascular malformations consisting of fragile and sinusoidal multivascular channels with no intervening brain tissue.[1] In supratentorial cavernomas, epileptic seizures occur in 40%–70% of cases, with 40% of cases presenting with drug-resistant epilepsy[2,3] and indicated for epilepsy surgery. For better seizure control, lesionectomy plus resection of the typically surrounding hemosiderin deposits is recommended.[4-6] However, the epileptogenic zone may be enlarged, or, especially in the temporal cavernomas, the hippocampus may have acquired secondary epileptogenicity at a distance from cavernoma lesions.[7] Intraoperative electrocorticography (ECoG) has been reported to be useful for finding the epileptogenic region, but it remains controversial due to the uncertainty in microscopic confirmation of hemosiderin deposits.[8-10] In cavernoma, Ferrier et al. suggested that the amount of hemosiderin deposits does not correlate with epileptic discharge patterns in the intraoperative ECoG and that a continuous spiking pattern may reflect secondary epileptogenicity.[11] They also indicated an association between the absence of a discharge pattern and a high microglial density with protective effects against epilepsy. Although the pathological mechanisms of epileptogenesis differ from disease to disease, there are indeed many similarities in the epileptic discharge patterns emanating from epileptogenic brain lesions such as glioneuronal tumor and cortical dysplasia.[12-14] We recently showed that high gamma oscillation (30–70 Hz) regularity (GOR) calculated with interictal ECoG data analysis could sensitively detect the epileptogenic zone in focal cortical dysplasia.[15,16] We hypothesized and tested whether this method could also be applied to epileptogenic zone localization in epilepsy surgery for cavernomas.

Study Description

Patients

We analyzed intraoperative ECoG data from 6 patients with medically refractory focal seizures secondary to cavernomas who underwent epilepsy surgery between April 2019 and March 2020 in the Department of Neurosurgery at Showa University School of Medicine. All patients met the following criteria: 1) the capture of habitual seizures with preoperative long-term video electroencephalographic (EEG) monitoring, 2) the presence of hemosiderin around the cavernoma confirmed by T2-weighted star magnetic resonance imaging, 3) the detection of the estimated epileptic focus by using interictal 123I-iomazenil single-photon emission computed tomography, and 4) the postsurgical histopathological diagnosis of cavernoma. The postsurgical seizure outcome was evaluated according to the International League Against Epilepsy classification system.[17] The resected tissues were evaluated by board-certified pathologists. This study was approved by the research ethics board at the Showa University School of Medicine. All procedures were performed according to the latest version of the Declaration of Helsinki. All patients gave informed consent.

Intraoperative ECoG Data Recordings

The grid electrodes (Unique Medical Co., Ltd.) were placed so that the cavernoma lesion was well covered, and they were also placed on the surface of the hippocampus in the cases with mesial temporal lobe epilepsy. The ECoG data were acquired using a Nihon Kohden Neurofax EEG system and a bandpass filter from 0.16 to 300 Hz with a sampling rate of 1 kHz. A 60-Hz notch filter was applied to all channels, and sensitivity was between 30 and 100 μV/mm according to the amplitudes of the background activities and epileptic discharges. The recordings were performed referentially with the reference electrode placed in the forehead or in an inactive area that never registered epileptic discharge. ECoG was also performed after resection. We randomly selected a 20-second epoch for GOR analysis for each patient. All selected epochs were inspected to ensure that they were not contaminated with artifacts.

GOR Analysis

The detailed algorithm for GOR analysis using the sample entropy method is described in our previous study.[15] The ECoG data were downsampled to 200 Hz, where the timescale factor τ = 3 to 7 corresponded to the gamma frequency (28.6–66.7 Hz). We defined the GOR as the average score with τ = 3 to 7. We calculated the GOR for 20-second epochs without any significant artifacts. Then we calculated the mean and standard deviation (SD) of the measured GOR within a given patient. Z values were calculated using the following equation: Z = (individual GOR − mean GOR)/(SD of GOR). Calculations were performed for each electrode of each patient. Z values less than −2 were defined as significant according to our previous report.[16] Lower Z values represent higher GOR. To visually assess the GOR, we created the color-coded GOR (opposite values of Z values) superimposed onto the electrodes of the subdural grid. These procedures were performed using a custom program developed in cooperation with EFken Inc.

Results

The results for each patient are summarized in Table 1 and Fig. 1. In 4 patients (cases 2, 3, 4, and 5), the GOR was significantly high in the area with the pathological hemosiderin deposition. In 2 patients (cases 1 and 6) with temporal cavernomas, the GOR was significantly high both in the hippocampus and in the area with the pathological hemosiderin deposition. Intraoperative ECoG showed no obvious epileptic waveforms in 3 patients (cases 3, 4, and 5) and extensive spikes in 3 patients, including microscopic normal areas around the lesions (cases 1, 2, and 6). In 2 patients with temporal cavernomas (cases 1 and 6), the spikes were also found in the ECoG on the surface of the hippocampus. All patients underwent cavernoma removal plus resection of the area with significantly high GOR, and hippocampal transection was added in 2 patients with temporal cavernomas (cases 1 and 6). The ECoG findings showed significant normalization, and the GOR showed decreased levels, in each patient after resection. Pathological hemosiderin deposition was observed in the resected regions with significantly high GOR in all 6 patients. All patients were seizure free at the follow-up after surgery.
TABLE 1.

Patient characteristics

Case No.SexAge (yrs)Cavernoma LocationSeizure TypeEpilepsy Surgery Plus Cavernoma RemovalNo. of Electrodes w/ Significantly High GORECoG FindingsPathological Hemosiderin DepositionPostsurgical Seizure Outcome
1
F
31
Lt temporal lobe
Focal impaired awareness seizure
Focal resection & hippocampal transection
2 on temporal lobe, 1 on hippocampus
Extensive spikes
+
Class I
2
F
45
Rt parietal lobe
Focal sensory seizure
Focal resection
1
Extensive spikes
+
Class I
3
M
42
Lt frontal lobe
Focal to bilat tonic-clonic seizure
Focal resection
1
None
+
Class I
4
F
47
Lt occipitoparietal lobe
Visual hallucination
Focal resection
1
None
+
Class I
5
M
24
Lt frontal lobe
Aphasic seizure
Focal resection
2
None
+
Class I
6M56Rt temporal lobeFocal impaired awareness seizureFocal resection & hippocampal transection3 on temporal lobe, 2 on hippocampusExtensive spikes+Class I

+ = present.

FIG. 1.

Results of 3 representative patients (cases 2, 4, and 6). For each patient, the columns (from left to right) show T2-weighted magnetic resonance imaging studies, intraoperative photographs of the brain surface, grid electrodes, ECoG findings, and color-coded GOR maps before (upper row) and after (lower row) resection. The red dotted circles in the GOR maps show the area with significantly high GOR, where the focal resection or hippocampal resection was performed. Pt = patient; ref = referential electrode.

Patient characteristics + = present. Results of 3 representative patients (cases 2, 4, and 6). For each patient, the columns (from left to right) show T2-weighted magnetic resonance imaging studies, intraoperative photographs of the brain surface, grid electrodes, ECoG findings, and color-coded GOR maps before (upper row) and after (lower row) resection. The red dotted circles in the GOR maps show the area with significantly high GOR, where the focal resection or hippocampal resection was performed. Pt = patient; ref = referential electrode.

Discussion

Observations

We believe that the significantly high GOR regions may be the epileptogenic zone in patients with cavernomas who have intractable focal epilepsy because (1) the good postsurgical seizure outcome was achieved in our 6 patients after removal of those high GOR locations and (2) the pathological hemosiderin deposition was observed in those regions that are normally difficult to identify microscopically. It has been demonstrated that complete resection of the hemosiderin deposits around cavernomas correlates with better postsurgical seizure outcomes.[4-6,8] Although careful intraoperative visualization of hemosiderin deposits is needed for epilepsy surgery, there is often no visible hemosiderin deposition on the brain surface (which was the case in all patients in this study). Furthermore, it has been reported that there is no association between Fe3+ staining and intraoperative ECoG discharge patterns,[11] and intraoperative ECoG assessment is not significantly reflected in postsurgical seizure outcomes for patients with cavernomas.[9] Indeed, intraoperative ECoG findings before resection did not show any significant epileptic discharges or extensive spikes in 3 of our patients, making it difficult to localize the epileptogenic area from these findings. Instead, limited resection of the areas with significantly high GOR resulted in ECoG normalization and an overall GOR decrease after resection in our 6 patients, which indicates that our GOR method could be more accurate than conventional ECoG assessment. In temporal cavernoma cases, previous studies have measured only conventional intraoperative ECoG epileptic discharges in temporal lobes. Although gross-total resection or aggressive resection has improved postsurgical seizure outcomes, it has also increased the risk of complications.[7,10,18] In our 2 patients with temporal cavernoma, ECoG before resection showed an extensive spiking pattern on the surface of the temporal lobe, including the cavernoma lesion, as well as on the hippocampal surface, whereas significantly high GOR areas were very localized. Interestingly, limited resection of areas with significantly high GOR improved ECoG dramatically not only in the areas around the lesions but also in the hippocampus, resulting in an overall decrease of GOR in both brain regions. This may also suggest that the measurement of high GOR can help surgeons to perform minimally invasive resection of epileptogenic regions in cavernoma surgery. Although the number of cases is small and our findings require further validation, we hope that our method will be widely used as a robust, minimally invasive, and safe intraoperative epileptogenic zone localization in epilepsy surgery for cavernomas.

Lessons

The high GOR may be a novel intraoperative marker of the epileptogenic zone in epilepsy surgery for cavernomas that does not yield significant findings on ECoG and in which no hemosiderin deposits are visible on the brain surface.

Acknowledgments

We thank Dr. Tohru Mizutani, Department of Neurosurgery, Showa University School of Medicine, for providing training in neurosurgical skills to Dr. Yosuke Sato. We also appreciate the assistance and support provided by Dr. Yoshihito Tsuji, Department of Neurosurgery, Matsubara Tokushukai Hospital, Osaka, Japan. Dr. Sato received funds from MEXT | Japan Society for the Promotion of Science (JSPS) and the Uehara Memorial Foundation.

Disclosures

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Author Contributions

Conception and design: Sato, Mizutani. Acquisition of data: all authors. Analysis and interpretation of data: Sato, Tsuji. Drafting the article: Sato, Tsuji. Critically revising the article: Sato, Tsuji. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Sato. Statistical analysis: Sato. Administrative/technical/material support: Sato, Sugiyama, Mizutani. Study supervision: Sato, Mizutani.
  18 in total

1.  Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations.

Authors:  Dario J Englot; Seunggu J Han; Michael T Lawton; Edward F Chang
Journal:  J Neurosurg       Date:  2011-08-05       Impact factor: 5.115

2.  Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy.

Authors:  T Hammen; J Romstöck; A Dörfler; F Kerling; M Buchfelder; H Stefan
Journal:  Seizure       Date:  2007-02-02       Impact factor: 3.184

3.  Low entropy of interictal gamma oscillations is a biomarker of the seizure onset zone in focal cortical dysplasia type II.

Authors:  Yosuke Sato; Ayako Ochi; Tohru Mizutani; Hiroshi Otsubo
Journal:  Epilepsy Behav       Date:  2019-05-28       Impact factor: 2.937

4.  ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery.

Authors:  H G Wieser; W T Blume; D Fish; E Goldensohn; A Hufnagel; D King; M R Sperling; H Lüders; T A Pedley
Journal:  Epilepsia       Date:  2001-02       Impact factor: 5.864

5.  Electrocorticographic discharge patterns in glioneuronal tumors and focal cortical dysplasia.

Authors:  Cyrille H Ferrier; Eleanora Aronica; Frans S S Leijten; Wim G M Spliet; Alexander C van Huffelen; Peter C van Rijen; Colin D Binnie
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

6.  Histopathological correlates of epileptogenicity as expressed by electrocorticographic spiking and seizure frequency.

Authors:  F Rosenow; H O Lüders; D S Dinner; R A Prayson; E Mascha; B R Wolgamuth; Y G Comair; G Bennett
Journal:  Epilepsia       Date:  1998-08       Impact factor: 5.864

7.  Pathological heterogeneity of angiographically occult vascular malformations of the brain.

Authors:  J R Robinson; I A Awad; T J Masaryk; M L Estes
Journal:  Neurosurgery       Date:  1993-10       Impact factor: 4.654

8.  Electrocorticography discharge patterns in patients with a cavernous hemangioma and pharmacoresistent epilepsy.

Authors:  Cyrille H Ferrier; Eleonora Aronica; Frans S S Leijten; Wim G M Spliet; Karin Boer; Peter C van Rijen; Alexander C van Huffelen
Journal:  J Neurosurg       Date:  2007-09       Impact factor: 5.115

9.  Surgical outcome in patients with epilepsy with occult vascular malformations treated with lesionectomy.

Authors:  D L Kraemer; M L Griebel; N Lee; A H Friedman; R A Radtke
Journal:  Epilepsia       Date:  1998-06       Impact factor: 5.864

10.  Surgical management of cavernous malformations presenting with drug-resistant epilepsy.

Authors:  Mario Arturo Alonso-Vanegas; José M Cisneros-Franco; Taisuke Otsuki
Journal:  Front Neurol       Date:  2012-01-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.